[throwawaypppu]

Similar to Pear Therapeutics that SPAC merge announced at $1.6B on about $500k revenue 12 months to date. Professional Analysts put stock target at twice first listing price. Had been around 10 years. Products in market for years. Market cap now $235M.Trading at or below cash.

[prewett]

Wow, that reminds me of Agillion, a dot-bomb which got $40 million of VC investment and $20 million in loans and had "hundreds of dollars" in sales. Plus $200k the founder(s) paid for the code in the bankruptcy.

[1] https://www.dcpartners.solutions/2022/02/agillion-what-was-i...